Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection (vol 5, pg 1489, 2013)

被引:0
作者
Chijioke, Obinna
Mueller, Anne
Feederle, Regina
Barros, Mario Henrique M.
Krieg, Carsten
Emmel, Vanessa
Marcenaro, Emanuela
Leung, Carol S.
Antsiferova, Olga
Landtwing, Vanessa
Bossart, Walter
Moretta, Alessandro
Hassan, Rocio
Boyman, Onur
Niedobitek, Gerald
Delecluse, Henri-Jacques
Capaul, Riccarda
Muenz, Christian
机构
关键词
D O I
10.1016/j.celrep.2015.07.041
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:901 / 901
页数:1
相关论文
共 45 条
[41]   MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia disease [J].
Brault, Julie ;
Meis, Ronald J. ;
Li, Linhong ;
Bello, Ezekiel ;
Liu, Taylor ;
Sweeney, Colin L. ;
Koontz, Sherry M. ;
Dowdell, Kennichi ;
Theobald, Narda ;
Lee, Janet ;
Allen, Cornell ;
Clark, Aaron B. ;
Ravell, Juan C. ;
Lenardo, Michael J. ;
Dahl, Gary A. ;
Malech, Harry L. ;
De Ravin, Suk See .
CYTOTHERAPY, 2021, 23 (03) :203-210
[42]   Epstein-Barr virus nuclear antigen 1 (EBNA1)-targeting probes stimulate interferon-β production by nasopharyngeal carcinoma (NPC) cells to enhance the natural killer cell-mediated cytotoxicity against NPC [J].
Chen, Luo ;
Liu, Xiao Han ;
Yuen, Hei Tung ;
Cho, William C. ;
Wong, Ka-Leung ;
Lung, Hong Lok .
CANCER RESEARCH, 2024, 84 (06)
[43]   Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions [J].
Zhang, Y ;
Nagata, H ;
Ikeuchi, T ;
Mukai, H ;
Oyoshi, MK ;
Demachi, A ;
Morio, T ;
Wakiguchi, H ;
Kimura, N ;
Shimizu, N ;
Yamamoto, K .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (05) :805-814
[45]   GENERATION OF DONOR-DERIVED MULTI-VIRUS SPECIFIC T CELLS (VST) TARGETING CYTOMEGALOVIRUS (CMV), EPSTEIN-BARR VIRUS (EBV), ADENOVIRUS, BK VIRUS AND SARS-COV2 TO PREVENT VIRAL INFECTION IN PATIENTS WITH SICKLE CELL DISEASE (SCD) AFTER BONE MARROW TRANSPLANT [J].
Motta, C. ;
Abraham, A. ;
Keller, M. ;
Bollard, C. .
CYTOTHERAPY, 2022, 24 (05) :S135-S135